Pear Therapeutics, Inc.
PEARDelisted May 2, 2023- Industry
- Services-Health Services
- SEC CIK
- 0001835567
Pear Therapeutics, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.7M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Pear Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 40 | 60 | +20 |
| Shares | 76.9M | 82.4M | +5.54M (+7.2%) |
| Value | $118.4M | $168.1M | +$49.7M (+42.0%) |
New holders (27)
Institutions that held Pear Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (7)
Institutions that held Pear Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HRT Financial LP | 201,829 | $310.0K |
| Ergoteles LLC | 72,098 | $111.0K |
| Two Sigma Investments, LP | 23,224 | $36.0K |
| Jump Financial, LLC | 20,335 | $31.0K |
| Penserra Capital Management LLC | 3,379 | $5.00K |
| Patriot Financial Group Insurance Agency, LLC | 500 | $1.00K |
| Highbridge Capital Management LLC | 99 | $0 |